Literature DB >> 21526942

Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.

Emanuele Durante-Mangoni1, Raffaele Zarrilli.   

Abstract

Acinetobacter baumannii is an opportunistic Gram-negative pathogen with increasing relevance in a variety of hospital-acquired infections especially among intensive care unit patients. Resistance to antimicrobial agents is the main reason for A. baumannii spread. A. baumannii outbreaks described worldwide are caused by a limited number of genotypic clusters of multidrug-resistant strains that successfully spread among hospitals of different cities and countries. In this article, we will focus on the mechanisms responsible for resistance to antimicrobials and disinfectants in A. baumannii and the epidemiology of drug-resistant A. baumannii in healthcare facilities. We will also discuss the therapeutic and infection control strategies for management of drug-resistant A. baumannii epidemics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21526942     DOI: 10.2217/fmb.11.23

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  52 in total

1.  Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection.

Authors:  Brittany L Mortensen; Eric P Skaar
Journal:  Cell Microbiol       Date:  2012-06-14       Impact factor: 3.715

2.  Drug-resistant gene of blaOXA-23, blaOXA-24, blaOXA-51 and blaOXA-58 in Acinetobacter baumannii.

Authors:  Chenggong Hou; Feng Yang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  Acinetobacter baumannii virulence determinants involved in biofilm growth and adherence to host epithelial cells.

Authors:  Raffaele Zarrilli
Journal:  Virulence       Date:  2016-02-08       Impact factor: 5.882

4.  Investigation of the molecular epidemiology of Acinetobacter baumannii isolated from patients and environmental contamination.

Authors:  Chunmei Ying; Yongli Li; Yaping Wang; Bing Zheng; Chengde Yang
Journal:  J Antibiot (Tokyo)       Date:  2015-04-15       Impact factor: 2.649

5.  Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump.

Authors:  Xinlong He; Feng Lu; Fenglai Yuan; Donglin Jiang; Peng Zhao; Jie Zhu; Huali Cheng; Jun Cao; Guozhong Lu
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

6.  Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway.

Authors:  Timothy R Sampson; Xiang Liu; Max R Schroeder; Colleen S Kraft; Eileen M Burd; David S Weiss
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

7.  Disruption of tetR type regulator adeN by mobile genetic element confers elevated virulence in Acinetobacter baumannii.

Authors:  Rajagopalan Saranathan; Sudhakar Pagal; Ajit R Sawant; Archana Tomar; M Madhangi; Suresh Sah; Annapurna Satti; K P Arunkumar; K Prashanth
Journal:  Virulence       Date:  2017-04-24       Impact factor: 5.882

8.  Acinetobacter baumannii response to host-mediated zinc limitation requires the transcriptional regulator Zur.

Authors:  Brittany L Mortensen; Subodh Rathi; Walter J Chazin; Eric P Skaar
Journal:  J Bacteriol       Date:  2014-05-09       Impact factor: 3.490

9.  Comparison of the Vitek 2, MicroScan, and Etest methods with the agar dilution method in assessing colistin susceptibility of bloodstream isolates of Acinetobacter species from a Korean university hospital.

Authors:  Seung Yeob Lee; Jong Hee Shin; Kyungwon Lee; Min Young Joo; Kyung Hwa Park; Myung Geun Shin; Soon Pal Suh; Dong Wook Ryang; Soo Hyun Kim
Journal:  J Clin Microbiol       Date:  2013-03-27       Impact factor: 5.948

10.  Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization.

Authors:  Jasmine Ahmed-Bentley; A Uma Chandran; A Mark Joffe; Desiree French; Gisele Peirano; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.